Research & Development

Implementing Research and Development projects is an integral part of BYS Grup’s core business activities. BYS Grup places a great importance on innovation.
ALZ-e-MED (E- MEDICAL PRIMARY CARE SYSTEM FOR ALZHEIMER’S PATIENTS)

The Project was carried out within the scope of EU FP7 between 2012 and 2014, with a budget of more than 1 Million Euro.

ALZ-e-MED is a comprehensive Alzheimer’s Disease Patient Lifecycle Management and Scoring System. Multiple challenges faced by patients and caregivers (when patients are cared for at home by relatives) can be overcome in an effective and cost-efficient manner with ALZ-e_MED’s scientifically developed modules such as Cognitive Exercises, Training Videos, Medication Reminders, etc.

Since the successful completion of the Project; commercialization and business development phases continue in the domestic and international markets.

For more information please visit ALZ-e-MED Official Website.

Alzemed

PRINTECELISA (PRINTED ELECTROCHEMICAL ELISA)

The purpose of the PRINTECELISA project which was run between 2013 and 2015, was to develop effective Printed Electrochemical ELISA Systems which aims to move the printing technologies already applied in other sectors to the Enzyme Linked Immunosorbent assays (ELISA) ELISA and (bio)sensors market.

BYS Grup took part in this EU 7th Framework Programme for Research (FP7) funded project together with DropSens (ES) from Spain. The total Budget of the project was approximately EURO 650.000.

ELDER TABLET (ELTAB)

The Elder Tablet is a prototype consisting of a tablet, medical and everyday devices, home sensors and a gateway with decision making support for the elderly. The Project was completed in 2015 with a budget of approximately 960.000 Euros.

The consortium partners of BYS Grup for this EU 7th Framework Programme for Research (FP7) project were CTI -DAISy Unit (Greece), Analogies S.A (Greece).